Literature DB >> 533700

Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics, and patients with pancreatitis and cancer of the pancreas.

H Rinderknecht, I G Renner, C Carmack.   

Abstract

Polyacrylamide gel electrophoresis of pure pancreatic juice from 14 healthy normal subjects, 11 chronic alcoholics without detectable pancreatic disease, 15 patients with pancreatitis, and two with cancer of the pancreas consistently demonstrated the presence of two variants of trypsinogen with different electrophoretic mobilities. In healthy normal subjects the proportion of cationic to anionic trypsinogen was invariably greater than 1 and averaged about 2. In chronic alcoholics, patients with pancreatitis or cancer of the pancreas, this ratio, with a single exception, was below one and averaged about 0.45. The extraordinary consistency of these findings suggests that the quantitative relationship between cationic and anionic trypsinogen in human pancreatic juice may be a very sensitive indicator of incipient or existing pancreatic pathology. The most acceptable explanation for the reversal of the normal zymogen ratio in pancreatic disease is a selective increase in the synthesis of the anionic variant relative to that of the cationic species. Total trypsinogen concentrations differed widely from one another in the three patient groups, but the ratio of cationic to anionic trypsinogen exhibited little change and remained below 1. Our results also demonstrate for the first time a specific effect of chronic alcohol abuse on the secretory profile of a pancreatic enzyme in human subjects. A newly discovered minor, trypsinogen-like component of human pancreatic juice was found to be significantly increased in pancreatic juice of chronic alcoholics, decreased in pancreatic secretions of patients with pancreatitis, and barely detectable in those of two patients with cancer of the pancreas.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 533700      PMCID: PMC1412706          DOI: 10.1136/gut.20.10.886

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Activation of human pancreatic juice.

Authors:  H Rinderknecht; I G Renner; C Carmack
Journal:  Clin Chim Acta       Date:  1976-12-01       Impact factor: 3.786

2.  [Chronic calcifying pancreatitis in Brazil: analysis of 92 cases (authors transl)].

Authors:  R Dani; C E Nogueira
Journal:  Leber Magen Darm       Date:  1976-10

Review 3.  Intrapancreatic activation of proteases in the etiology of pancreatitis and cancer of the pancreas.

Authors:  T T White; B J Allan
Journal:  Med Clin North Am       Date:  1974-11       Impact factor: 5.456

4.  On bovine and porcine anionic trypsinogens.

Authors:  M N Louvard; A Puigserver
Journal:  Biochim Biophys Acta       Date:  1974-11-05

5.  Trypsin in human pancreatic juice--their distributions as found in 34 specimens. Two human pancreatic trypsinogens.

Authors:  L A Robinson; W J Kim; T T White; B Hadorn
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

6.  Chronic alcoholism and carcinoma of the pancreas. A correlative hypothesis.

Authors:  G E Burch; A Ansari
Journal:  Arch Intern Med       Date:  1968-09

7.  A new, highly sensitive and specific assay for chymotrypsin.

Authors:  H Rinderknecht; R M Fleming
Journal:  Clin Chim Acta       Date:  1975-03-10       Impact factor: 3.786

8.  Two human trypsinogens. Purification, molecular properties, and N-terminal sequences.

Authors:  O Guy; D Lombardo; D C Bartelt; J Amic; C Figarella
Journal:  Biochemistry       Date:  1978-05-02       Impact factor: 3.162

9.  Profiles of pure pancreatic secretions obtained by direct pancreatic duct cannulation in normal healthy human subjects.

Authors:  H Rinderknecht; I G Renner; A P Douglas; N F Adham
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

  9 in total
  31 in total

Review 1.  Biochemical models of hereditary pancreatitis.

Authors:  Miklós Sahin-Tóth
Journal:  Endocrinol Metab Clin North Am       Date:  2006-06       Impact factor: 4.741

Review 2.  Human pancreatic digestive enzymes.

Authors:  David C Whitcomb; Mark E Lowe
Journal:  Dig Dis Sci       Date:  2007-01-05       Impact factor: 3.199

Review 3.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

Review 4.  Biochemical and structural insights into mesotrypsin: an unusual human trypsin.

Authors:  Moh'd A Salameh; Evette S Radisky
Journal:  Int J Biochem Mol Biol       Date:  2013-09-13

5.  Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis.

Authors:  U Petersson; S Appelros; A Borgström
Journal:  Int J Pancreatol       Date:  1999-06

6.  Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation.

Authors:  Vanda Toldi; András Szabó; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2020-02-03       Impact factor: 5.157

7.  A possible zymogen self-destruct mechanism preventing pancreatic autodigestion.

Authors:  H Rinderknecht; N F Adham; I G Renner; C Carmack
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb

8.  Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen.

Authors:  András Szabó; Miklós Sahin-Tóth
Journal:  FEBS J       Date:  2012-10-30       Impact factor: 5.542

9.  Abnormalities in pancreatic secretory profiles of patients with cancer of the pancreas.

Authors:  H Rinderknecht; I G Renner; N H Stace
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

10.  Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors.

Authors:  Richárd Szmola; Zoltán Kukor; Miklos Sahin-Tóth
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.